Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (27825)	4/30/1998 2:02:00 PM
From: MythMan	Read Replies (1) \| Respond to of 132070

MB & Mike M, Since you guys trashed my last post, perhaps you'll find this one more agreeable <g> usatoday.com

To: Knighty Tin who wrote (27825)	4/30/1998 3:08:00 PM
From: yard_man	Read Replies (1) \| Respond to of 132070

Great One. Is this the great pre-earnings run-up for DELL or shall we wait for another?

To: Knighty Tin who wrote (27825)	5/1/1998 1:55:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 132070

Michael/Tom: OK, I'll post tomorrow. I was super impressed with the presentation. I watched it sneak back up, and decided a couple of days ago to get back in when it looked like it was going to accelerate. My two biggest neuros....... both ran at the close today with both the bid and ask above the last trade. It may have been Elan's purchase of NXCO, but I don't think so. NGD 91-2 is looking good, I believe. 91-1 was in over 1,000 patients in that phase I context. Pfizer just loved it. 91-2 doesn't have the absorption issue ass'd with it. So.... while the other projects look good, I'd say that anxiety still looks hot. Lots of projects, lots of hits. While it has made the teens to twenties trips several times, it's only going to take one good transition to phase II and, IMO, it's not coming back. The program is that broad and diversified, backed by plenty of cash. Rick